During the past decade, Region Östergötland conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Region Östergötland" #1 collaborator was "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator, "European Myeloma Network" with 1 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "Kamprad Family Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Region Östergötland" are "Chronic Lymphocytic Leukemia in Relapse" (1 trials), "Chronic Lymphocytic Leukemia in Remission" (1 trials), "Healthy" (1 trials), "Hematologic Malignancy" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Region Östergötland" in a lesser frequency.

Most popular intervention types in "Region Östergötland" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials), "Education" (1 trials) and "Ibrutinib + Venetoclax 15 cycles" (1 trials). Other intervention names were less common.

The vast majority of trials in "Region Östergötland" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Region Östergötland". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were undefined completed trials in Region Östergötland, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Region Östergötland, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Region Östergötland has several departments that took part in Clinical trials: "Universitetssjukhuset i Linköping, Hematologkliniken" - 6 trials, "Universitetssjukhuset; Onkologkliniken" - 2 trials